Published on 09/07/2021
12-15 November, 2021 Hybrid edition
ENYO Pharma will attend the 2021 edition of AASLD / The Liver meeting.
ENYO Pharma announces a €39 million Series C financing and FDA clearance to advance Vonafexor in a Phase 2 clinical trial for patients with Alport syndrome.ENYO Pharma announ...